Title 26, HEALTH AND VITAL STATISTICS

26:2-111.7 "Let Them Be Little Act," screening of newborns for MPSI and MPSII provided. 1. a. All infants born in this State shall be tested for mucopolysaccharidosis I (MPS I), also known as Hurler syndrome, Hurler-Scheie syndrome, or Scheie syndrome, beginning six months follow…

26:2-111.8 Screening of newborn infants for spinal muscular atrophy. 1. a. Each infant born in this State shall be tested for the genetic mutations associated with spinal muscular atrophy. b. The Commissioner of Health shall develop a comprehensive program of follow-up services a…

26:2-111.9 All infants tested, congenital cytomegalovirus; opting out of testing. 1. a. All infants born in this State shall be tested for congenital cytomegalovirus infection (cCMV), unless an infant's parent or legal guardian opts out of testing, beginning six months following …

26:2-112. Agreements with federal government and public health agencies of other states The commissioner is authorized to enter into agreements with the Federal Government and public health agencies in other states to achieve greater effectiveness or efficiency in carrying out th…

26:2-113. Legislative findings and declarations The Legislature finds that the effective identification, diagnosis, care and treatment of persons who have been exposed to diethylstilbestrol, commonly referred to as DES, is of paramount public importance; that DES, a synthetic est…

26:2-114. Definitions As used in this act: a. "Primary screening" means the initial evaluation of a person through history, physical examination and routine tests to determine the possible existence of physical changes due to diethylstilbestrol exposure; and b. "Secondary screeni…

26:2-115. Duties of commissioner; programs of education; secondary screening programs The Commissioner of the Department of Health shall establish: a. A program to educate the public and health care professionals involved in primary screening about the potential hazards and affli…

26:2-116. Registry The Commissioner of the Department of Health shall maintain a registry of women who took diethylstilbestrol during pregnancy and their offspring who were exposed to diethylstilbestrol prenatally for the purpose of follow-up care and treatment of long-term probl…

26:2-117. Annual report The Department of Health shall make an annual report to the Legislature, through the President of the Senate, Speaker of the General Assembly and Chairmen of the Senate and Assembly Institutions, Health and Welfare Committees of its findings and recommenda…

26:2-119. Legislative findings The Legislature finds that every year there are a substantial number of accidental poisonings especially among young children and that the possibility of serious injury or death which results from the ingestion of poisonous substances could be drama…

26:2-120. Definitions As used in this act: a. "Commissioner" means the Commissioner of the Department of Health; b. "Program" means the poison control and drug information program established by the commissioner. L.1982, c. 177, s. 2, eff. Nov. 12, 1982.

26:2-121. Poison control and drug information program; establishment; hours of service The commissioner shall establish a Statewide program of poison control and drug information. Program services shall be available on a 24 hour basis to the residents of every county. L.1982, c. …

26:2-122. Services performed The principal activity of the program shall be answering requests by telephone for poison information and making recommendations for appropriate management and treatment of poisoning exposure and overdose victims. Services of the poison control and dr…

26:2-123. Personnel utilization The program shall utilize physicians, pharmacists, nurses and other necessary personnel trained in various aspects of toxicology, poison control, and drug information retrieval and analysis. L.1982, c. 177, s. 5, eff. Nov. 12, 1982.

26:2-124. Findings, declarations The Legislature finds and declares that the rising incidence of heart disease, kidney disease and stroke is causing increased concern among public health officials and private practitioners who feel that it is imperative that new initiatives be de…

26:2-125. Definitions As used in this act: a. "Commissioner" means the Commissioner of the Department of Health; b. "Department" means the State Department of Health; c. "Program" means the hypertension control program established by the commissioner. L. 1985, c. 5, s. 2, eff. Ja…

26:2-126. Expansion of hypertension control program The commissioner shall expand the existing hypertension control program within the department, which shall have central authority and responsibility for the development of a system of community based high blood pressure control …

26:2-127 Components of community program. 4. A community based high blood pressure control program shall provide: a. Hypertension screening; b. Treatment referral; c. Counseling for persons with high blood pressure as to proper diet, weight control, and appropriate care and treat…

26:2-128 Authority of commissioner. 5. The commissioner is authorized to: a. Enter into necessary contracts and agreements with counties, municipalities and other units of government, colleges, universities, associations, agencies, corporations, and individuals for the developmen…

26:2-129. Regulations Pursuant to the "Administrative Procedure Act," P.L. 1968, c. 410 (C. 52:14B-1 et seq.), the commissioner shall promulgate any regulations necessary to effectuate the provisions of this act. L. 1985, c. 5, s. 6, eff. Jan. 10, 1985.

26:2-130. Findings, declarations The Legislature finds and declares that: a. Exposure to lead and lead poisoning leads to morbidity, mortality, mental retardation, and learning disability in young children, the monetary and social costs of which far exceed the costs of monitoring…

26:2-131 Definitions. 2. As used in this act: "Child" means a person one through five years of age. "Commissioner" means the Commissioner of Health. "Department" means the Department of Health. "Lead poisoning" means the poisoning of the bloodstream that results from prolonged ex…

26:2-132. Lead poisoning control program The department, within the limits of funds appropriated for this purpose, has the responsibility for the development, implementation and coordination of a program to control lead poisoning and abate identified lead hazards by: a. Identifyi…

26:2-134. Comprehensive plan Within six months of the effective date of this act, the commissioner shall prepare a comprehensive plan to control lead poisoning in the State. The commissioner shall submit the plan to the Governor and the Legislature. L. 1985, c. 84, s. 5, eff. Mar…

26:2-135. Annual report 6. The commissioner shall issue an annual report to the Governor and the Legislature by October 1 of each year. The report shall include a summary of the lead poisoning testing and abatement program activities in the State during the preceding fiscal year …

26:2-136. Loans to local boards The department may set aside up to 10% of the funds appropriated pursuant to this act for the purpose of providing loans to local boards of health to abate lead paint nuisances pursuant to section 9 of P.L. 1971, c. 366 (C. 24:14A-9). The departmen…

26:2-137. Regulations The commissioner shall, pursuant to the provisions of the "Administrative Procedure Act," P.L. 1968, c. 410 (C. 52:14B-1 et seq.), adopt regulations necessary to effectuate the provisions of this act. L. 1985, c. 84, s. 8, eff. March 25, 1985.

26:2-137.1 Specifications for lead screening of children, immunizations. 7. The Department of Health shall specify by regulation, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.): a. The lead screening requirements provided for under P.L.1995, …

26:2-137.10 Laboratory to submit lead screening results, prenatal maternity care, to Department of Health. 3. A laboratory which performs a lead screening test pursuant to subsection a. of section 2 of this act shall report the test results to the department, the local health dep…

26:2-137.11 Lead screenings, prenatal maternity care, records included in central database. 4. a. A record of all lead screenings conducted pursuant to section 2 of this act shall be included in the central database maintained by the department in accordance with provisions of se…

26:2-137.2 Findings, declarations relative to lead exposure of children. 1. The Legislature finds and declares that: a. According to the New Jersey Department of Health, 630,000 children under the age of six are at risk of lead poisoning in New Jersey and should be screened for e…

26:2-137.3 Definitions relative to lead exposure. 2. As used in this act: "Commissioner" means the Commissioner of Health. "Department" means the Department of Health. "Elevated blood lead level" means a level of lead in the bloodstream that equals or exceeds five micrograms per …

26:2-137.4 Lead screening performed; requirements. 3. a. A physician or registered professional nurse, as appropriate, shall perform lead screening on each patient under six years of age to whom the physician or registered professional nurse provides health care services, unless …

26:2-137.5. Blood samples; collection, testing 4. a. All lead screening blood samples collected by a physician, registered professional nurse or a health care facility pursuant to this act shall be sent to a laboratory licensed by the Department of Health, pursuant to the "New Je…

26:2-137.6 Central database maintained; confidentiality. 5. a. The department shall maintain a central database which shall include a record of all lead screening conducted pursuant to this act. The database shall include the name, age and address of the child screened and any ot…

26:2-137.7. Rules, regulations 6. The commissioner shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.) necessary to carry out the provisions of this act. L.1995,c.328,s.6.

26:2-137.8 Definitions. 1. As used in this act: “Department” means the Department of Health. “Lead screening” means the application of a detection technique to measure a person’s blood lead level and determine the extent of the person’s recent exposure to lead. L.2025, c.193, s.1…

26:2-137.9 Lead screening, prenatal maternity care. 2. a. A licensed health care professional, which shall include a licensed physician, licensed physician assistant, certified advanced practice nurse, certified nurse midwife, certified professional midwife, and certified midwife…

26:2-138. Findings, declarations The Legislature finds and declares that the rising incidence of diabetes mellitus and its associated complications involving the eyes, kidneys, heart, blood vessels and nerves is causing concern among public health officials and private practition…

26:2-139. Definitions As used in this act: a. "Commissioner" means the Commissioner of the State Department of Health; b. "Department" means the State Department of Health; c. "Program" means the Diabetes Control Program established by the commissioner. L. 1987, c. 10, s. 2.

26:2-140. Program continued The commissioner shall continue within the department the existing Diabetes Control Program which shall have central authority and responsibility for the development of diabetes control strategies based on sound scientific principles and protocols. L. …

26:2-141 Duties, powers. 4. The commissioner is authorized to: a. Gather data relative to the occurrence of diabetes and its associated complications; b. Enter into necessary contracts and agreements with counties, municipalities, and other units of government, colleges, universi…

26:2-142. Rules, regulations Pursuant to the "Administrative Procedure Act," P.L. 1968, c. 410 (C. 52:14B-1 et seq.), the commissioner shall promulgate rules and regulations necessary to effectuate the provisions of this act. L. 1987, c. 10, s. 5.

26:2-142.1 Diabetes action plan, report to Governor, Legislature. 1. a. The Department of Health, in consultation with the Department of Human Services and the Department of Children and Families, shall develop a diabetes action plan to reduce the impact of diabetes in the State …

26:2-143. Blood specimen from all pregnant women Every licensed physician or other licensed health professional engaged in the prenatal care of a pregnant woman or attending the woman at the time of delivery, miscarriage or abortion shall obtain or cause to be obtained a blood sp…

26:2-144. Determination of Rh blood type The physician or licensed health professional shall submit the blood specimen to a licensed clinical laboratory or a laboratory approved by the State Department of Health for a determination of rhesus (Rh) blood type. The laboratory shall …